COVID VACCINE STOCKS react to the JNJ vaccine pause news with a strong rally - climbing 3.5% on average. Fully 19 of the stocks managed gains after several weeks of weakness.
The biggest gainers were the established covid vaccine makers: #1 Novavax gained 11%, while #2 Moderna gained over 7% with BioNTech gaining just under 7%.
The strongest gain was in GeoVax which climbed 15%.
Several smaller secondary companies also had very strong days: Adaptive (up 8%), Arcturus and iBio, up 7%, Inovio, Vaxart, PDS Bio and NanoViricides all gained 6%.
Emergent Bio continued its recent weakness, falling another 4%.
No comments:
Post a Comment